| Filed On | Filing |
|---|---|
| 19 Dec 2022 |
Form 4/A: Thorp Clay, Director
Sold 32,873 shares ($146K) |
| 28 Jan 2022 |
Form 4/A: Ciulla Thomas, Chief Medical Officer
Received 46,250 shares as a grant or award · Granted 138,750 Stock Option (Right to Buy) |
| 28 Jan 2022 |
Form 4/A: Deignan Charles A., Chief Financial Officer
Received 46,250 shares as a grant or award · Granted 138,750 Stock Option (Right to Buy) |
| 13 Aug 2020 |
Form 4/A: Whitmore Bradford T, 10% owner
Bought 300,000 shares ($489K) · Bought 50,000 shares ($82.6K) |
Loading...
